A5023323769- Cancer survivorship and care
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Health and Wellbeing Research
- Glioma Diagnosis and Treatment
- Family Support in Illness
- Bladder and Urothelial Cancer Treatments
- Patient-Provider Communication in Healthcare
- Immunotherapy and Immune Responses
- Sexual function and dysfunction studies
- Cardiovascular Health and Risk Factors
- Fibromyalgia and Chronic Fatigue Syndrome Research
- Global Cancer Incidence and Screening
- Childhood Cancer Survivors' Quality of Life
- Cancer-related cognitive impairment studies
- BRCA gene mutations in cancer
- Immune cells in cancer
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Immune Cell Function and Interaction
- Cancer Cells and Metastasis
- Cutaneous Melanoma Detection and Management
- Caveolin-1 and cellular processes
- Garlic and Onion Studies
- Health Systems, Economic Evaluations, Quality of Life
University of Zurich
2017-2021
NYU Langone Health
2020
German Cancer Research Center
2019
Netherlands Comprehensive Cancer Organisation
2019
Heidelberg University
2019
University of Oxford
1980
Abstract Glioblastoma is the most common malignant brain tumor and patients usually succumb to their disease within 2 years. Aldehyde dehydrogenase 1A1 (ALDH1A1) has been suggested as a marker for cancer stem cells that associated with poor prognosis in human gliomas. However, little known about expression function of ALDH1A1 early stages development. We analyzed developing mature central nervous system (CNS) well 93 cases primary glioblastomas. Surprisingly, was absent cell niches at...
Abstract Purpose Cancer‐related fatigue (CRF) is one of the most prevalent symptoms experienced by cancer survivors. However, researchers are only beginning to elucidate risk factors, underlying mechanism(s), and its association with other outcomes. Research on between CRF mortality limited. Methods The study sample comprised 2059 short‐term (<5 years postdiagnosis) survivors from four PROFILES registry studies. Survivors diagnosed stage I‐III colorectal (CRC) or endometrial (EC), no...
Aside from urological and sexual problems, long-term (≥5 years after initial diagnosis) prostate cancer (PC) survivors might suffer pain, fatigue, depression. These concurrent symptoms can form a cluster. In this study, we aimed to investigate classes of symptom cluster in PC survivors, classify accordingly, explore associations between health-related quality life (HRQoL).
Several therapies for localised prostate cancer (PC) are available; all yield similar survival rates. However, each therapy has significant side effects that can influence patients' health-related quality of life (HRQoL) in the long run.The study sample included 911 survivors with PC, 5-15 years post-diagnosis who were identified from population-based CAESAR + Germany. HRQoL was assessed using EORTC QLQ-C30 and QLQ-PR25 questionnaires. The association between type multivariable linear...
Data about delay in receiving treatment were obtained from 162 women with newly diagnosed breast cancer. Delay was found to occur both before and after the woman presented her general practitioner. Women tended because they assumed that their symptoms not serious or due something other than cancer, of domestic responsibilities. Delays within Health Service mostly diagnostic administrative problems. Particular difficulties arose where doctors expected benign disease, typical cancer had a...
Abstract Background Nerve‐sparing (NS) surgery was developed to improve postoperative sexual and potentially urological outcomes after radical prostatectomy (RP). However, it is largely unknown how NSRP affects health‐related quality of life (HRQoL) including urinary in prostate cancer (PC) survivors 5‐10 years diagnosis comparison with Non‐NSRP. Methods The study population included 382 stage pT2‐T3N0M0 PC post diagnosis, who were identified from the multiregional Prostate Cancer...
Abstract Background: Nerve-sparing (NS) surgery was developed to improve postoperative sexual and potentially urological outcomes after radical prostatectomy (RP). However, it is largely unknown how NSRP affects health-related quality of life (HRQoL) including urinary in prostate cancer (PC) survivors 5-10 years diagnosis comparison Non-NSRP. Methods: The study population included 382 stage pT2-T3N0M0 PC post-diagnosis, who were identified from the multiregional Prostate Cancer Survivorship...